TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
PLX

Protalix Biotherapeutics Inc

Healthcare · Biotechnology

2.80$ -1.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Protalix Biotherapeutics Inc (PLX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 110 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PLX
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
70 82 72 59 61 72 65 52 67 61 61 55 54 45 83 72 72 68 103 108 83 74 68 61 57 56 67 88 88 84 90 92 62 73 74 78 82 82 102 110
60 72 62 49 51 63 56 43 57 53 47 42 40 32 58 54 60 56 91 96 71 62 57 50 46 45 55 74 73 70 75 77 48 60 61 65 67 67 86 92
51 63 48 35 33 51 41 28 42 38 30 25 21 18 14 4.8 14 18 20 34 11 39 17 12 11 17 33 48 20 24 27 23 27 20 19 18 14 15 42 27
51 63 48 35 33 51 41 28 42 38 30 25 21 18 37 35 41 39 70 77 49 39 33 29 21 22 33 48 41 45 48 45 27 35 35 33 29 30 52 41
2.1 0.7 2.7 3.0 7.3 1.7 4.8 5.2 4.9 4.7 8.6 7.3 8.7 4.7 8.9 5.3 3.1 2.0 4.6 2.3 5.6 3.4 5.9 2.0 8.7 4.6 1.3 4.0 8.9 5.3 3.8 10 2.2 2.9 4.7 9.4 14 8.8 2.9 17
4.9 5.2 7.1 7.1 7.5 7.8 7.0 7.0 8.0 8.6 6.7 7.0 7.5 8.2 9.5 11 13 13 14 14 15 18 17 17 15 17 20 20 22 19 22 21 17 21 20 21 21 26 30 32
9.1 8.7 8.5 8.2 8.0 7.7 7.3 6.9 6.6 6.4 6.1 5.9 11 5.3 5.0 4.8 4.6 10 4.8 10 10 9.9 9.8 9.5 9.5 9.6 4.7 4.6 11 – – – 10 10 10.0 9.7 13 13 – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
86 92 140 80 87 104 104 101 132 114 121 123 125 116 114 106 106 95 88 104 83 80 76 71 68 66 66 49 49 51 60 63 29 30 29 29 29 34 35 39
10 66 20 19 27 23 21 15 15 25 27 26 33 40 48 42 44 86 81 96 43 33 35 31 34 32 32 23 43 46 55 58 24 26 24 24 22 27 27 31
72 54 54 58 5.9 5.9 5.9 32 62 – 1.3 1.2 1.2 5.4 5.4 5.4 5.5 60 57 58 4.5 1.2 1.2 1.1 1.0 1.1 1.1 1.3 22 22 22 23 1.5 1.5 1.4 1.5 1.4 1.4 1.4 1.7
4.0 4.0 6.0 7.9 8.7 7.5 4.9 6.0 4.4 5.2 5.9 6.7 7.8 6.5 9.4 6.7 8.4 7.2 6.4 6.1 8.4 7.0 7.9 7.0 5.6 5.9 5.1 3.3 3.1 4.3 3.1 4.1 3.1 4.5 4.1 6.7 5.4 5.3 4.3 6.5
72 24 118 58 58 51 51 52 47 52 49 49 50 51 52 53 54 – – – 28 28 28 28 28 28 28 20 – – – – – – – – – – – –
-15 -10.0 -68 -21 -26 -31 -39 -50 -65 -53 -60 -67 -71 -70 -31 -35 -33 -27 15 3.8 0.2 -6.0 -7.5 -9.9 -12 -11 1.0 39 38 34 30 29 32 43 45 50 53 48 67 71
-210 -213 -272 -271 -283 -298 -303 -319 -334 -323 -330 -337 -341 -341 -339 -343 -348 -347 -353 -364 -368 -375 -377 -383 -386 -390 -393 -374 -376 -382 -386 -388 -385 -378 -382 -382 -379 -385 -367 -363
10.0 12 12 19 13 15 15 15 15 15 15 15 15 15 17 32 33 33 40 45 46 46 46 47 49 51 57 83 84 73 73 73 81 81 77 81 81 79 83 83

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?